Dr Sally Wheelwright

Following a degree in Natural Sciences (Experimental Psychology) at the University of Cambridge, Sally Wheelwright remained in Cambridge to research reading development for a year followed by 15 years of autism research. In 2010, she moved to the Faculty of Medicine at the University of Southampton to develop quality of life questionnaires and complete a PhD, focussing on cancer cachexia (uncontrolled, unintentional weight loss and muscle wasting). In 2017, Sally joined the Macmillan Survivorship Research Group in Health Sciences, University of Southampton to work on prospective longitudinal cohort studies exploring the recovery of health and wellbeing in adults diagnosed with cancer.

Sally joined SHORE-C in October 2021. Her research interests centre round supporting self-management of nutritional care in people with cancer and long term conditions, along with quality of life assessment, health literacy and developing digital interventions.

  • I-Prehab

    I-Prehab will develop a toolkit to support cancer workers to raise awareness of and encourage participation in prehabilitation, particularly with people from socially deprived and ethnically minoritised communities.

  • Palmieri C, Linden H, Birrell SN, Wheelwright S, Lim E, Schwartzberg LS ... B. Overmoyer (2024). Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial. The Lancet Oncology. Find it online here 08/02/2024
  • Wheelwright S, Matthews L, Jenkins V, May S, Rea D, Fairbrother P, Gaunt C, Young J, Pirrie S, Wallis M G, Fallowfield L, on behalf of the LORIS Trial Management Group (2023). Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study. Trials; 24(1): 670. Find it online here 14/10/2023
  • Davies S, & Wheelwright S. (2023) The impact of jejunostomy feeding on nutritional outcomes after oesophagectomy. Journal of Human Nutrition and Dietetics; 2023: 1- 11. Find it online here 04/10/2023
  • Wheelwright S, Maunsell R, Taylor S, Drinkwater N, Erridge C, Foster C, ... & White S. (2023). Development of 'gastrostomy tube - is it for me?', a web-based patient decision aid for people living with motor neurone disease considering having a gastrostomy tube placed. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration; 24 (7-8): 605-613. Find it online here 19/07/2023
  • Myall M, Taylor S, Wheelwright S, & Lund S. (2023). Domestic Abuse in the Context of Life-Limiting Illness: A Systematic Scoping Review. Health & Social Care in the Community; 2023. Find it online here 12/04/2023
  • Taylor S, Wheelwright S, and White S. (2023) The DiAMoND Study: Development and pilot testing of a web-based decision aid for people with motor neurone disease considering a gastrostomy tube. Complete Nutrition; 22 (9): 28-30. Find it online here 22/01/2023
  • McCracken J, Wheelwright S, Hon Y, & Shaw C. (2022) Experience, decision-making and information needs around parenteral nutrition among people with advanced cancer, and their carers: A scoping review. Journal of Human Nutrition and Dietetics; 36(2): 453-467. Find it online here 14/10/2022
  • Amdal C D, Taylor K, Kuli D, Falk R S, Bottomley A, Arraras J I, ... & Bjordal K. (2022). Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure. Journal of Patient-Reported Outcomes; 6(1): 26. Find it online here 26/03/2022
  • Fitzsimmons D, & Wheelwright S. (2022). Developing Cancer Quality of Life Assessment Tools. In Handbook of Quality of Life in Cancer;(pp. 39-60). Cham: Springer International Publishing. Find it online here 26/03/2022
  • Glasspool R, Wheelwright S, Bolton V, Calman L, Cummings A, Elledge B, ... & Foster C. (2022). Modifiable pre-treatment factors are associated with quality of life in women with gynaecological cancers at diagnosis and one year later: Results from the HORIZONS UK national cohort study.Gynecologic Oncology; 165(3): 610-618. Find it online here 26/03/2022